Artiva Biotherapeutics (ARTV) Amortizatization of Intangibles (2023 - 2026)
Artiva Biotherapeutics (ARTV) reported Amortizatization of Intangibles of $199000.0 for Q1 2026, down 72.48% year-over-year from $723000.0 in Q1 2025, and down 31.62% quarter-over-quarter from $291000.0 in Q4 2025.
Artiva Biotherapeutics (ARTV) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of Amortizatization of Intangibles data on file, last reported at $199000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $199000.0, down 72.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (down 49.72% YoY), and the FY2025 annual result was $1.9 million, down 19.73% from the prior year.
- Amortizatization of Intangibles retreated to $199000.0 in Q1 2026 per ARTV's latest filing, from $291000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.0 million in Q4 2024 and troughed at $159000.0 in Q3 2023.
- A 4-year average of $442090.9 and a median of $357000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2024 and 2026: Amortizatization of Intangibles jumped 314.47% in 2024, then tumbled 72.48% in 2026.
- A 4-year view of Amortizatization of Intangibles shows it stood at $283000.0 in 2023, then surged by 268.2% to $1.0 million in 2024, then sank by 72.07% to $291000.0 in 2025, then slumped by 31.62% to $199000.0 in 2026.
- Business Quant data shows ARTV's Amortizatization of Intangibles at $199000.0 in Q1 2026, $291000.0 in Q4 2025, and $357000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Artiva Biotherapeutics | 241.85 Mn | 241.85 Mn | - | 199,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 199,000.00 |
| Mar 31, 2026 | 199,000.00 |
| Dec 31, 2025 | 291,000.00 |
| Dec 31, 2025 | 291,000.00 |
| Sep 30, 2025 | 357,000.00 |
| Sep 30, 2025 | 357,000.00 |
| Jun 30, 2025 | 509,000.00 |
| Jun 30, 2025 | 509,000.00 |
| Mar 31, 2025 | 723,000.00 |
| Mar 31, 2025 | 723,000.00 |
| Dec 31, 2024 | 1.04 Mn |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 659,000.00 |
| Sep 30, 2024 | 659,000.00 |
| Jun 30, 2024 | 273,000.00 |
| Jun 30, 2024 | 273,000.00 |
| Mar 31, 2024 | 368,000.00 |
| Mar 31, 2024 | 368,000.00 |
| Dec 31, 2023 | 283,000.00 |
| Dec 31, 2023 | 283,000.00 |